带有传感器的阿里皮普拉片的现实世界证据:治疗模式和对精神病医疗保健资源利用的影响
Dusica Hadzi Boskovic1, Shuting Liang2, Purva Parab2
1Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, NJ, USA.
ClinicoEconomics and outcomes research : CEOR
|June 28, 2023
概括
具有传感器 (AS) 的阿里皮普拉片改善了抗精神病药物 (AP) 药物坚持和减少精神病医疗资源利用率 (HCRU) 在现实世界中使用. 这项技术有望改善患者的治疗结果和管理心理健康状况.
科学领域:
- 精神病学是一个精神病学.
- 数字健康数字健康
- 医疗保健服务研究 医疗服务研究
背景情况:
- 药物坚持是管理精神疾病的一个重大挑战.
- 带有传感器 (AS) 的阿里皮普拉片提供了关于药物摄入的客观数据.
- 需要关于AS使用及其对医疗保健资源利用 (HCRU) 影响的真实数据.
研究的目的:
- 为了评估AS使用的现实世界治疗模式.
- 评估AS对精神病医疗资源利用 (HCRU) 的影响.
主要方法:
- 使用索赔数据进行回顾性,观察性队列研究.
- 倾向性得分匹配 (4:1) 来比较AS启动者与控制.
- 对抗精神病药物 (AP) 供应日和精神病学HCRU频率的分析.
主要成果:
- 与对照组相比,AS发起者的AP供应日数增加了41% (P <0.0001).
- 自闭症患者的精神病诊所门诊次数 (aOR=0.80),急诊室次数 (aOR=0.11) 和住院次数 (aOR=0.42) 的几率显著降低.
- AS使用与整体精神病 HCRU 的降低有关.
结论:
- AS的实施导致了AP供应的增加和精神病治疗访问的减少.
- AS技术可能有助于建立定期服用药物的习惯.
- 用更大的样本进行进一步的研究是有必要的,以支持临床实践和覆盖决策.
相关概念视频
Drug Therapy
74
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
74
Antipsychotic Drugs: Typical and Atypical Agents
263
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
263
Psychosis: Goals of Pharmacotherapy
171
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
171
Psychosis and Antipsychotic Drugs: Overview
348
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
348
Antipsychotic Drugs: Therapeutic Uses and Side Effects
272
Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
272
Pharmacovigilance
908
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
908


